Feasibility of Risk Sign Displays to Prevent Falls, Dehydration and Pulmonary Aspiration in Nursing Homes
![]() |
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. |
ClinicalTrials.gov Identifier: NCT03123601 |
Recruitment Status :
Completed
First Posted : April 21, 2017
Last Update Posted : March 21, 2019
|
- Study Details
- Tabular View
- No Results Posted
- Disclaimer
- How to Read a Study Record
BACKGROUND: Prior research has shown a relationship between dehydration, falls and pulmonary aspiration among older adults in nursing and health care facilities, which contributes to its loss of independence and quality-of-life. Is believed that improving communication among health professional decreases the number of adverse events in institutionalized patients. This study will evaluate the feasibility of a set of sign displays designed to communicate fall, dehydration and pulmonary aspiration risks and will reflect on tailored interventions to manage these events in nursing homes.
METHODS AND ANALYSIS: This will be a national, single-center, feasibility study. All patients, with chronic neurologic diseases selected from a nursing home, will be invited to participate. At baseline patients will undertake a screening risk assessment and it will be attributed a correspondent risk display. Study duration will be a minimum of 3 months per participant, including daily record of events and monthly interview assessments. Events data will be compared with historical data extracted retrospectively from medical and nursing charts.
Condition or disease | Intervention/treatment | Phase |
---|---|---|
Nursing Home Residents | Device: Risk sign displays | Not Applicable |

Study Type : | Interventional (Clinical Trial) |
Actual Enrollment : | 20 participants |
Allocation: | N/A |
Intervention Model: | Single Group Assignment |
Intervention Model Description: | All patients, with chronic neurologic diseases selected from a nursing home, will be invited to participate. At baseline patients will undertake a screening risk assessment and it will be attributed a correspondent risk display. Study duration will be a minimum of 3 months per participant, including daily record of events and monthly interview assessments. Events data will be compared with historical data extracted retrospectively from medical and nursing charts. |
Masking: | None (Open Label) |
Primary Purpose: | Device Feasibility |
Official Title: | Feasibility of Risk Sign Displays to Prevent Falls, Dehydration and Pulmonary Aspiration in Nursing Homes: a Clinical Study Protocol |
Actual Study Start Date : | November 1, 2016 |
Actual Primary Completion Date : | April 30, 2017 |
Actual Study Completion Date : | May 30, 2017 |

Arm | Intervention/treatment |
---|---|
Experimental: Risk sign displays
At baseline patients will undertake a screening risk assessment and it will be attributed a correspondent risk display. Study duration will be a minimum of 3 months per participant, including daily record of events and monthly interview assessments. Events data will be compared with historical data extracted retrospectively from medical and nursing charts.
|
Device: Risk sign displays
Set of sign displays designed to communicate fall, dehydration and pulmonary aspiration risks and reflect on tailored interventions to manage these events in nursing homes. Risk sign displays are:
|
- Patients' adherence trough the number of times and reasons to taken off the risk display or refused to use during the period of the study and/or withdrawing from the study [ Time Frame: Minimum of 3 months ]
- Patients' satisfaction with the sign displays measured with a 7-point likert scale and open-ended questions. [ Time Frame: Minimum of 3 months ]
- Health professionals' satisfaction measured with sign displays through 7-point likert scale and open-ended questions regarding the overall benefits of using the displays and overall perception of its impact on decreasing risk. [ Time Frame: Minimum of 3 months ]
- Comparison to historical medical and nursing charts data review of the relative frequency of number of events per number of days of hospitalization registered during the period of the study, with in an equal period of time, one year before. [ Time Frame: Minimum of 3 months ]
- Type and frequency of adverse events recorded during the period of the study [ Time Frame: Minimum of 3 months ]

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.
Ages Eligible for Study: | Child, Adult, Older Adult |
Sexes Eligible for Study: | All |
Accepts Healthy Volunteers: | No |
Inclusion criteria:
- Male or female staying at CNS nursing home for long term care;
- Risk of falling and/or dysphagia and/or dehydration defined by brief screening assessment;
- Being interested in participating in this study;
- Signing an informed consent form;
- Willing to comply with the monthly interviews required
- Eligibility validated by CNS health professionals in the multidisciplinary clinical meeting
Exclusion criteria:
- Having significant active psychiatric problems (example: hallucinations, confusion, psychosis) that aggravates patient´s symptoms when dealing with the use of sign displays;
- Inability participate according to the CNS health professionals' judgement

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.
Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT03123601
Portugal | |
Campus Neurológico Sénior | |
Torres Vedras, Portugal, 2560-280 Torres Vedras |
Principal Investigator: | Joaquim J Ferreira, MD, PhD | Campus Neurológico Sénior |
Responsible Party: | Campus Neurológico Sénior |
ClinicalTrials.gov Identifier: | NCT03123601 |
Other Study ID Numbers: |
CNS2017-01 |
First Posted: | April 21, 2017 Key Record Dates |
Last Update Posted: | March 21, 2019 |
Last Verified: | March 2019 |
Individual Participant Data (IPD) Sharing Statement: | |
Plan to Share IPD: | No |
Studies a U.S. FDA-regulated Drug Product: | No |
Studies a U.S. FDA-regulated Device Product: | No |
Nursing home Falls Dysphasia Choking Dehydration |
Dehydration Water-Electrolyte Imbalance Metabolic Diseases Pathologic Processes |